[Psychotropic drugs in internal medicine. III. Uses and indications in non-psychiatric patients].
D002032:Bulimia / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004700:Endocrine System Diseases / Q000188:drug therapy; D006402:Hematologic Diseases / Q000188:drug therapy; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D008881:Migraine Disorders / Q000188:drug therapy; D009069:Movement Disorders / Q000188:drug therapy; D018377:Neurotransmitter Agents / Q000502:physiology; D010146:Pain / Q000188:drug therapy; D010437:Peptic Ulcer / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000494:pharmacology / Q000627:therapeutic use*
D018377:Neurotransmitter Agents; D011619:Psychotropic Drugs; D016651:Lithium Carbonate; D008094:Lithium
Psicofármacos en medicina interna. III. Usos e indicaciones en pacientes no psiquiatricos.